This is where you will find financial information about Promore Pharma. You can download annual reports, quarterly reports and presentations and subscribe to our press releases and reports.
It is our ambition to provide the capital market, investors, shareholders and other stakeholders with relevant information to facilitate a fair valuation of the company and our external contacts. We strive to be as transparent as possible in all our actions. Do not hesitate to contact us if you require additional information.
- Promore Pharma granted US patent regarding treatment of chronic wounds
- Interim report January – September 2021
- Invitation to Conference Call regarding Promore Pharma’s Interim Report for the Third Quarter 2021
- Nomination Committee Appointed for the Annual General Meeting 2022 in Promore Pharma
- Promore Pharma receives permits to start a phase II clinical trial regarding scar prevention